Characterization of the Rac guanine nucleotide exchange factor P-Rex1 in platelets
Journal of Molecular Signaling volume 6, Article number: 11 (2011)
Blood platelets undergo a carefully regulated change in shape to serve as the primary mediators of hemostasis and thrombosis. These processes manifest through platelet spreading and aggregation and are dependent on platelet actin cytoskeletal changes orchestrated by the Rho GTPase family member Rac1. To elucidate how Rac1 is regulated in platelets, we captured Rac1-interacting proteins from platelets and identified Rac1-associated proteins by mass spectrometry.
Here, we demonstrate that Rac1 captures the Rac guanine nucleotide exchange factor P-Rex1 from platelet lysates. Western blotting experiments confirmed that P-Rex1 is expressed in platelets and associated with Rac1. To investigate the functional role of platelet P-Rex1, platelets from P-Rex1 -/--deficient mice were treated with platelet agonists or exposed to platelet activating surfaces of fibrinogen, collagen and thrombin. Platelets from P-Rex1 -/- mice responded to platelet agonists and activating surfaces similarly to wild type platelets.
These findings suggest that P-Rex1 is not required for Rac1-mediated platelet activation and that the GEF activities of P-Rex1 may be more specific to GPCR chemokine receptor mediated processes in immune cells and tumor cells.
Upon exposure to agonist signals of vascular injury, platelets spread out on sites of vessel damage to form thrombotic plugs [1, 2]. During this process, platelets undergo an ordered series of shape changes that are determined by a spatial reorganization of the actin cytoskeleton . These geometric changes that occur in the activated platelet are regulated by many of the same proteins that confer motility and regulate the cytoskeleton in nucleated cells, namely the Rho family of GTPases, including Cdc42, Rac1, and RhoA . Accordingly, conditional knock-out mice models deficient in Rac1 do not undergo normal platelet spreading or aggregation and form a weak primary platelet plug over a site of vascular injury . Similarly, constitutive deactivation of RhoA in platelets results in reduced platelet adhesion and an unstable thrombus .
Rho family GTPases are regulated in a cyclical manner by different classes of Rho-GTPase binding proteins. When platelets are stimulated to form a plug over the site of vascular injury, guanine nucleotide exchange factors (GEFs) such as Vav1 bind the Rac1 GTPase in its GDP conjugated form and catalyze a nucleotide exchange reaction to form Rac1-GTP . Rac1-GTP is then able to bind downstream effecter proteins that regulate cytoskeletal proteins to form actin and myosin filaments. While Vav1 is known to control Rac1-based thrombotic activities in platelets, other well-established Rac1 GEFs have not been explored in regulating thrombosis.
To better understand how Rac1 is activated in platelets, we captured Rac1-associated proteins from platelet lysates and identified potential Rac1 regulatory proteins from thrombin-stimulated platelets by mass spectrometry. Platelets were purified from platelet rich plasma from healthy volunteers with Ficoll-Paque 400  and adjusted to a concentration of 1 × 109/ml. Lysates were prepared from resting platelets or platelets activated with 5 U/ml thrombin for 5 minutes. Immobilized Rac1-GST or GDP and GTP-loaded Rac1-GST were added to precleared lysates and incubated for 1 hour at 4°C. Rac1-associated proteins were eluted into Laemelli sample buffer and separated by PAGE. Silver-stained gel slabs from thrombin stimulated Rac1-GST eluates corresponding to 70 - 250 kD (Figure 1A, lanes 6, 7 and 8) were each separately digested with trypsin and resulting peptide fragments were analyzed with a ThermoFinnegan LTQ quadrupole linear ion trap spectophotometer fitted with an Ion Max nanospray source. Mass spectra were analyzed with Sequest software (Proteomics Shared Research Center, OHSU) and sequences were compared using Scaffold 2.1 software. Mass spectrometry capture experiments revealed that GTP-loaded Rac1-GST captured the Rac1 GEF P-Rex1 from thrombin-stimulated platelet lysates. Nine unique trypsin-digested P-Rex1 peptides were recovered (Table 1), representing 6% sequence coverage (103/1659 amino acids). Platelet lysates and Rac1-GST eluates were western blotted for the presence of P-Rex1 (Figure 1B), confirming that P-Rex1 is abundant in human platelets (input) and associated with Rac1 in vitro.
P-Rex1 functions as a specific Rac1 and Rac2 activator in neutrophils [9, 10], endothelial cells  and breast cancer cells . Intriguingly, the guanine nucleotide exchange activity of P-Rex1 is known to be regulated by both Gβ/γ and phosphoinositol-3,4,5 phosphate (PIP3) [9, 13, 14], suggesting that P-Rex1 could be involved in regulating G-protein coupled receptor (GPCR) pathways triggered by platelet agonists such as thrombin [15, 16] and ADP . Interestingly, we found that a ternary complex consisting of P-Rex1, Rac1-GTP and Gβ/γ occurs only in the thrombin-activated platelets (data not shown). P-Rex1 activity is also regulated through mTOR signaling , and recent work has described a role for mTOR in the activation of platelet Rac1 through an undetermined mechanism . Accordingly, we hypothesized that P-Rex1 may function as an important Rac activator in response to stimulation of PARs and other platelet GPCRs.
Thrombin markedly upregulated Rac1 activity in platelets from wild type mice as determined by capture of activated Rac1-GTP from quiescent versus stimulated platelet lysates  (Figure 1C). Protein capture and western blotting analyses confirmed that P-Rex1 is expressed in mouse platelets and capable of associating with GTP-loaded Rac1 (Figure 1D). To determine if P-Rex1 has a role in GPCR-triggered and Rac1-dependent platelet lamellipodia formation and surface spreading, we isolated platelets from P-Rex1-deficeint mice  and exposed them to platelet activating surfaces. Washed mouse platelets (2 × 107/ml) from wild type (P-Rex1 +/+) or P-Rex1 -/- mice were placed on 100 μg/ml fibrinogen-coated coverglass in the presence of vehicle, the ADP scavenger apyrase (2 U/ml), or the GPCR agonists thrombin (1 U/ml) or ADP (10 μM) for 45 minutes at 37°C and were examined using differential interference contrast (DIC) microscopy. Platelets from wild type and P-Rex1 -/- mice attached to fibrinogen surfaces at the same level (Figure 2A). The addition of the platelet GPCR agonists thrombin or ADP triggered platelet spreading on a surface of fibrinogen to a similar extent in both wild type and P-Rex1 -/- platelets (Figure 2A). Deletion of P-Rex1 similarly had no effect on the spreading of platelets on a surface of fibrillar collagen (Figure 2B) or thrombin (Figure 2C).
In conclusion, our study demonstrates that Rac1 interacts with P-Rex1 from platelets, however, the GEF activity of P-Rex1 is not likely essential to PAR and P2Y GPCR- and Rac1-mediated platelet lamellipodia formation and spreading. These results suggest that the activities of P-Rex1 may perhaps be more specific to GPCR chemokine receptor (CXCR)-mediated events in immune cells  and tumor cells [12, 20–22]. While P-Rex1 alone does not appear to have a requisite role in activating Rac1 in platelets, recent studies suggest that P-Rex1 can work together with Vav1 to contribute to Rac1 activation . Whether or not P-Rex1 has a secondary role in regulating platelet Rac1 activation and the potential context of such an accessorizing function of P-Rex1 in platelets remains to be determined.
guanine nucleotide exchange factor
G-protein coupled receptor
Mammalian Protein Extraction Reagent
mammalian target of rapamycin
protease activated receptor
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1.
Furie B, Furie BC: Thrombus formation in vivo. J Clin Invest 2005,115(12):3355–3362.
Ruggeri ZM: Platelets in atherothrombosis. Nat Med 2002,8(11):1227–1234.
Watson SP: Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. Curr Pharm Des 2009,15(12):1358–1372.
Bishop AL, Hall A: Rho GTPases and their effector proteins. Biochem J 2000,348(Pt 2):241–255.
McCarty OJ, Larson MK, Auger JM, Kalia N, Atkinson BT, Pearce AC, Ruf S, Henderson RB, Tybulewicz VL, Machesky LM, et al.: Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J Biol Chem 2005,280(47):39474–39484.
Schoenwaelder SM, Hughan SC, Boniface K, Fernando S, Holdsworth M, Thompson PE, Salem HH, Jackson SP: RhoA sustains integrin alpha IIbbeta 3 adhesion contacts under high shear. J Biol Chem 2002,277(17):14738–14746.
Pearce AC, Wilde JI, Doody GM, Best D, Inoue O, Vigorito E, Tybulewicz VL, Turner M, Watson SP: Vav1, but not Vav2, contributes to platelet aggregation by CRP and thrombin, but neither is required for regulation of phospholipase C. Blood 2002,100(10):3561–3569.
Andersen H, Greenberg DL, Fujikawa K, Xu W, Chung DW, Davie EW: Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci USA 1999,96(20):11189–11193.
Welch HC, Coadwell WJ, Ellson CD, Ferguson GJ, Andrews SR, Erdjument-Bromage H, Tempst P, Hawkins PT, Stephens LR: P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 2002,108(6):809–821.
Welch HC, Condliffe AM, Milne LJ, Ferguson GJ, Hill K, Webb LM, Okkenhaug K, Coadwell WJ, Andrews SR, Thelen M, et al.: P-Rex1 regulates neutrophil function. Curr Biol 2005,15(20):1867–1873.
Carretero-Ortega J, Walsh CT, Hernandez-Garcia R, Reyes-Cruz G, Brown JH, Vazquez-Prado J: Phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 (P-Rex-1), a guanine nucleotide exchange factor for Rac, mediates angiogenic responses to stromal cell-derived factor-1/chemokine stromal cell derived factor-1 (SDF-1/CXCL-12) linked to Rac activation, endothelial cell migration, and in vitro angiogenesis. Mol Pharmacol 2010,77(3):435–442.
Sosa MS, Lopez-Haber C, Yang C, Wang H, Lemmon MA, Busillo JM, Luo J, Benovic JL, Klein-Szanto A, Yagi H, et al.: Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell 2010,40(6):877–892.
Barber MA, Donald S, Thelen S, Anderson KE, Thelen M, Welch HC: Membrane translocation of P-Rex1 is mediated by G protein betagamma subunits and phosphoinositide 3-kinase. J Biol Chem 2007,282(41):29967–29976.
Hill K, Krugmann S, Andrews SR, Coadwell WJ, Finan P, Welch HC, Hawkins PT, Stephens LR: Regulation of P-Rex1 by phosphatidylinositol (3,4,5)-trisphosphate and Gbetagamma subunits. J Biol Chem 2005,280(6):4166–4173.
Huang JS, Dong L, Kozasa T, Le Breton GC: Signaling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion. J Biol Chem 2007,282(14):10210–10222.
Azim AC, Barkalow K, Chou J, Hartwig JH: Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor. Blood 2000,95(3):959–964.
Gachet C: P2 receptors, platelet function and pharmacological implications. Thromb Haemost 2008,99(3):466–472.
Hernandez-Negrete I, Carretero-Ortega J, Rosenfeldt H, Hernandez-Garcia R, Calderon-Salinas JV, Reyes-Cruz G, Gutkind JS, Vazquez-Prado J: P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration. J Biol Chem 2007,282(32):23708–23715.
Aslan JE, Tormoen GW, Loren CP, Pang J, McCarty OJ: S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation. Blood 2011.
Qin J, Xie Y, Wang B, Hoshino M, Wolff DW, Zhao J, Scofield MA, Dowd FJ, Lin MF, Tu Y: Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis. Oncogene 2009,28(16):1853–1863.
Johansson FK, Goransson H, Westermark B: Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene 2005,24(24):3896–3905.
Montero JC, Seoane S, Ocana A, Pandiella A: P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer. Oncogene 2011,30(9):1059–1071.
Lawson CD, Donald S, Anderson KE, Patton DT, Welch HC: P-Rex1 and Vav1 cooperate in the regulation of formyl-methionyl-leucyl-phenylalanine-dependent neutrophil responses. J Immunol 2011,186(3):1467–1476.
Aslan JE, You H, Williamson DM, Endig J, Youker RT, Thomas L, Shu H, Du Y, Milewski RL, Brush MH, et al.: Akt and 14–3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis. Mol Cell 2009,34(4):497–509.
Itakura A, Aslan JE, Sinha S, White-Adams TC, Patel IA, Meza-Romero R, Vandenbark AA, Burrows GG, Offner H, McCarty OJ: Characterization of human platelet binding of recombinant T cell receptor ligand. J Neuroinflammation 2010, 7:75.
We thank L. David of the OHSU Proteomics Shared Research Center for mass spectrometry services. This work was supported by that National Institute of Health grants T32HL007781 (J.E.A.) and R01HL101972 (O.J.T.M.) and the American Heart Association 09GRNT2150003 (O.J.T.M.). The authors have no conflicts of interest to declare.
The authors declare that they have no competing interests.
All authors designed and carried out experiments. JEA wrote the manuscript. HCW supplied P-Rex1 -/- mice. All authors read and approved the final manuscript.
About this article
Cite this article
Aslan, J.E., Spencer, A.M., Loren, C.P. et al. Characterization of the Rac guanine nucleotide exchange factor P-Rex1 in platelets. J Mol Signal 6, 11 (2011). https://doi.org/10.1186/1750-2187-6-11